AQUILA STUDY IN GERMANY - REAL WORLD ADHERENCE AND PERSISTENCE OF SECUKINUMAB TREATMENT IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS - AN INTERIM ANALYSIS

被引：8
|
作者：
Kiltz, Uta [1 ,2 ]
Peterlik, Daniel [3 ]
Winkelmann, Veronika [3 ]
Tony, Hans-Peter [4 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Ruhr Univ, Bochum, Germany
[3] Novartis Pharma GmbH, Clin Res Immunol Hepatol & Dermatol, Nurnberg, Germany
[4] Univ Klin, Med Klin 2, Rheumatol Immunol, Wurzburg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY; DOUBLE-BLIND;
D O I：
10.1136/annrheumdis-2019-eular.435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0705
引用
收藏
页码：1814 / 1815
页数：2
相关论文
共 50 条
  • [21] The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis
    Karatas, Ahmet
    Gercek, Aybuke Nisa
    Oz, Burak
    Gozel, Nevzat
    Sagir, Rabia Piskin
    Gur, Mustafa
    Koca, Suleyman Serdar
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2020, 7 (04) : 169 - 172
  • [22] Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Elewski, Boni E.
    Baddley, John W.
    Deodhar, Atul A.
    Magrey, Marina
    Rich, Phoebe A.
    Soriano, Enrique R.
    Soung, Jennifer
    Bao, Weibin
    Keininger, Dorothy
    Marfo, Kwaku
    Patekar, Manmath
    Sharma, Abhishek
    Shete, Abhijit
    Lebwohl, Mark Gabriel
    JAMA DERMATOLOGY, 2021, 157 (01) : 43 - 51
  • [23] DOES SMOKING AFFECT SECUKINUMAB TREATMENT OUTCOMES AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY
    Riechers, E.
    Kiltz, U.
    Brandt-Juergens, J.
    Kaestner, P.
    Peterlik, D.
    Tony, H. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 729 - 729
  • [24] SECUKINUMAB RETENTION AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: 2 YEAR INTERIM RESULTS OF THE OBSERVATIONAL SERENA STUDY
    Kiltz, U.
    Sfikakis, P.
    Gullick, N.
    Theodoridou, A.
    Brandt-Juergens, J.
    Lespessailles, E.
    Rashkov, R.
    Fang, J.
    Pournara, E.
    Schulz, B.
    Jagiello, P.
    Gaffney, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 337 - 338
  • [25] Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis
    Deodhar, Atul
    Gladman, Dafna D.
    McInnes, Iain B.
    Spindeldreher, Sebastian
    Martin, Ruvie
    Pricop, Luminita
    Porter, Brian
    Safi, Jorge, Jr.
    Shete, Abhijit
    Bruin, Gerard
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (04) : 539 - 547
  • [26] DOES SMOKING AFFECT SECUKINUMAB TREATMENT OUTCOMES AND SAFETY IN PATIENTS WITH PSORIATIC ARTHRITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY
    Riechers, E.
    Kiltz, U.
    Brandt-Juergens, J.
    Kastner, P.
    Peterlik, D.
    Tony, H. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1707 - 1707
  • [27] PREDICTION OF LOW DISEASE ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH SECUKINUMAB IN REAL WORLD - DATA FROM THE GERMAN AQUILA STUDY
    Vodencarevic, A.
    Brandt-Juergens, J.
    Peterlik, D.
    Gmeiner, B.
    Kiltz, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 38 - 38
  • [28] SECUKINUMAB RETENTION AND SAFETY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: TWO-YEAR INTERIM RESULTS OF THE OBSERVATIONAL SERENA STUDY
    Gaffney, Karl
    Kiltz, Uta
    Sfikakis, Petros
    Gullick, Nicola
    Theodoridou, Athina
    Brandt-Juergens, Jan
    Lespessailles, Eric
    Fang, Juanzhi
    Pournara, Effie
    Schulz, Barbara
    Jagiello, Piotr
    RHEUMATOLOGY, 2022, 61
  • [29] How Does Time to Diagnosis and Gender Affect Treatment Outcomes in Patients with Ankylosing Spondylitis or Psoriatic Arthritis? - Real World Data from a German Observational Study with Secukinumab
    Benesova, Karolina
    Hansen, Oliver
    Kiltz, Uta
    Brandt-Juergens, Jan
    Kaestner, Peter
    Riechers, Elke
    Peterlik, Daniel
    Budden, Christina
    Boas, Annika
    Welle, Stefanie
    Tony, Hans-Peter
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2957 - 2959
  • [30] HOW DOES GENDER AFFECT SECUKINUMAB TREATMENT OUTCOMES AND RETENTION RATES IN PATIENTS WITH ANKYLOSING SPONDYLITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY
    Kiltz, U.
    Brandt-Juergens, J.
    Kaestner, P.
    Riechers, E.
    Peterlik, D.
    Tony, H. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 706 - 707
12345